The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Express Scripts Holding Co

Nasdaq: ESRX
Last

(U.S.) $89.23

Today's change-0.84 -0.93%
Updated August 3 4:00 PM EDT. Delayed by at least 15 minutes.
 

Express Scripts Holding Co

Nasdaq: ESRX
Last

(U.S.) $89.23

Today's change-0.84 -0.93%
Updated August 3 4:00 PM EDT. Delayed by at least 15 minutes.

Express Scripts Holding Co crosses below 50-day moving average

Express Scripts Holding Co closed lower Monday, dropping (U.S.)$0.84 or 0.93% to (U.S.)$89.23 and crossing below its 50-day moving average. Shares have lost 2.05% over the last five days, but have gained 5.39% over the last year to date. This security has outperformed the S&P 500 by 18.18% during the last year.

Key company metrics

  • Open(U.S.) $90.06
  • Previous close(U.S.) $90.07
  • High(U.S.) $90.86
  • Low(U.S.) $88.32
  • Bid / Ask-- / --
  • YTD % change+5.39%
  • Volume5,598,982
  • Average volume (10-day)4,349,824
  • Average volume (1-month)3,740,481
  • Average volume (3-month)4,212,161
  • 52-week range(U.S.) $68.78 to (U.S.) $94.61
  • Beta1.37
  • Trailing P/E29.26×
  • P/E 1 year forward16.40×
  • Forward PEG1.28×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.05
Updated August 3 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.60%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue25,45424,90026,31325,779
Total other revenue--------
Total revenue25,45424,90026,31325,779
Gross profit2,1721,8892,2752,138
Total cost of revenue23,28223,01124,03823,641
Total operating expense24,32224,07325,37024,794
Selling / general / administrative910953950931
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)129109383223
Other operating expenses, total--------
Operating income1,133827943984
Interest income (expense), net non-operating-132-116-122-202
Gain (loss) on sale of assets--------
Other--------
Income before tax1,006716831798
Income after tax606447589589
Income tax, total400268242209
Net income600441582582
Total adjustments to net income--------
Net income before extra. items600441582582
Minority interest-6-6-7-7
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items600441582582
Inc. avail. to common incl. extra. items600441582582
Diluted net income600441582582
Dilution adjustment--------
Diluted weighted average shares681735738746
Diluted EPS excluding extraordinary itemsvalue per share0.880.600.790.78
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.990.691.161.00